INTERNATIONAL PATENT: LASK PHARMA, INC. FILES APPLICATION FOR "SOLUBLE BONE MORPHOGENETIC PROTEIN (BMP) RECEPTOR TYPE-1B PROTEINS AND USES THEREOF"

GENEVA, Feb. 18 -- LASK PHARMA, INC. (280 Moody Street, Unit 3Waltham, MA 02453) filed a patent application (PCT/US2024/040876) for "SOLUBLE BONE MORPHOGENETIC PROTEIN (BMP) RECEPTOR TYPE-1B PROTEINS AND USES THEREOF" on Aug 02, 2024. With publication no. WO/2025/034616, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KNOPF, John (c/o Lask Pharma, Inc.280 Moody Street, Unit 3Waltham, MA 02453)

Abstract: This application relates generally to the field of Bone Morphogenetic Protein (BMP) antagonists (soluble ALK6 fusion ...